ReviewOncology reviews2025
Personalized exercise programs in oncology.
Review in Oncology reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Informational and structural barriers to exercise oncology care in Spain: development of the MOVE-Onco questionnaire and preliminary findings.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
- Perceived Barriers and Facilitators to Physical Activity Engagement Among Cancer Survivors: A Qualitative Study.Cancers · 2026Article
- Exercise-specific post-translational modification signatures: unveiling precise regulatory mechanisms of molecular exercise language and cellular adaptation.Frontiers in sports and active living · 2026Review
- Cisplatin-Induced Skeletal Muscle Atrophy: Biomolecular Mechanisms and the Protective Role of Exercise-Induced Myokines.Biomolecules · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exercise is increasingly recognized as a safe and effective adjunct therapy across the cancer care continuum, offering improvements in physiological function, psychological wellbeing, and treatment outcomes. However, conventional one-size-fits-all exercise prescriptions often fall short of addressing the diverse needs of cancer patients, who differ significantly in tumor type, treatment modality, baseline fitness, and comorbidities. Personalized exercise programs offer a tailored, evidence-informed approach that enhances safety, adherence, and clinical benefits. This narrative review synthesizes the current literature on the physiological, psychological, and oncological impacts of exercise in cancer care, emphasizing the rationale, methodologies, and emerging tools for individualized exercise prescriptions. Integration of such programs into oncology practice requires standardized assessments, interdisciplinary collaboration, and digital infrastructure, with a focus on addressing barriers to implementation and ensuring equitable access. Personalized exercise programs have the potential to improve patient outcomes and survivorship experiences across diverse cancer populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.